Evidence map›Paper›PMID 38253597›Full record

ArticleRMD open2024

Human leucocyte antigens and Japanese patients with polymyalgia rheumatica: the protective effect of

Shinichi Nogi, Shomi Oka, Takashi Higuchi, Hiroshi Furukawa, Kota Shimada, Takanori Azuma, Takao Sugiyama, Fuminori Hirano, Akira Okamoto, Misuzu Fujimori and 9 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RMD open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 1 country.

Shinichi NogiDepartment of Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Japan.
Shomi OkaDepartment of Clinical Research, NHO Tokyo National Hospital, Kiyose, Japan.
Takashi HiguchiDepartment of Clinical Research, NHO Tokyo National Hospital, Kiyose, Japan.
Hiroshi FurukawaDepartment of Clinical Research, NHO Tokyo National Hospital, Kiyose, Japan furukawa-tky@umin.org.ORCID 0000-0003-1353-8056
Kota ShimadaDepartment of Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Japan.
Takanori AzumaAzuma Rheumatology Clinic, Sayama, Japan.
Takao SugiyamaDepartment of Rheumatology, NHO Shimoshizu Hospital, Yotsukaido, Japan.
Fuminori HiranoDepartment of Internal Medicine, NHO Asahikawa Medical Center, Asahikawa, Japan.
Akira OkamotoDepartment of Rheumatology, NHO Himeji Medical Center, Himeji, Japan.
Misuzu FujimoriDepartment of Rheumatology, NHO Himeji Medical Center, Himeji, Japan.
Yoshiro HoraiClinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
Atsushi IhataDepartment of Rheumatology, NHO Yokohama Medical Center, Yokohama, Japan.
Atsushi HashimotoDepartment of Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Japan.
Akiko KomiyaClinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Japan.
Toshihiro MatsuiDepartment of Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Japan.
Naoshi FukuiClinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Japan.
Masao KatayamaDepartment of Internal Medicine, NHO Nagoya Medical Center, Nagoya, Aichi, Japan.
Kiyoshi MigitaClinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
Shigeto TohmaDepartment of Clinical Research, NHO Tokyo National Hospital, Kiyose, Japan.
National Sagamihara Hospital · JPHimeji Medical Center · JPAsahikawa Medical University · JPFukushima Medical University · JPNagoya Medical Center · JPSasebo City General Hospital · JPShizuoka City Shimizu Hospital · JPTokyo National Hospital · JPTokyo University of the Arts · JP

Funding

Japan Society for the Promotion of Science 26293123, 22591090, 15K09543, 18K08402
6 · The paper itself

Abstract

objectiveThe hallmarks of the chronic inflammatory disease polymyalgia rheumatica (PMR) include pain, and morning stiffness in areas of the neck, shoulder and pelvic girdle. The human leucocyte antigen (

methodsGenotyping of

results

conclusionThis study is the first to demonstrate predisposing associations of

Indexed as

Giant Cell ArteritisHLA-DR AntigensPolymyalgia RheumaticaEpitopesHLA AntigensHumansJapanPainEpitopesHLA AntigensHLA-DR Antigensepidemiologypolymorphism, geneticpolymyalgia rheumatica

Identifiers

PMID38253597
PMCPMC10806501
OpenAlexW4391116455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.